Cargando…

Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study

BACKGROUND: Oxidative stress plays an important role in the course and eventual outcome in a majority of patients admitted to the intensive care unit (ICU). Markers to estimate oxidative stress are not readily available in a clinical setting. AGEs accumulation has been merely described in chronic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Greven, Wendela L, Smit, Jitty M, Rommes, Johannes H, Spronk, Peter E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887805/
https://www.ncbi.nlm.nih.gov/pubmed/20500823
http://dx.doi.org/10.1186/1472-6890-10-4
_version_ 1782182587313160192
author Greven, Wendela L
Smit, Jitty M
Rommes, Johannes H
Spronk, Peter E
author_facet Greven, Wendela L
Smit, Jitty M
Rommes, Johannes H
Spronk, Peter E
author_sort Greven, Wendela L
collection PubMed
description BACKGROUND: Oxidative stress plays an important role in the course and eventual outcome in a majority of patients admitted to the intensive care unit (ICU). Markers to estimate oxidative stress are not readily available in a clinical setting. AGEs accumulation has been merely described in chronic conditions, but can also occur acutely due to oxidative stress. Since AGEs have emerged to be stable end products, these can be a marker of oxidative stress. Skin autofluorescence (AF) is a validated marker of tissue content of AGEs. We hypothesized that AGEs accumulate acutely in ICU patients. METHODS: We performed an observational prospective study in a medical surgical ICU in a university affiliated teaching hospital. All consecutively admitted ICU patients in a 2 month period were included. Skin AF was measured using an AGE reader in 35 consecutive ICU patients > 18 yrs. As a comparison, historical data of a control group (n = 231) were used. These were also used to calculate age-adjusted AF-levels (AF(adj)). Values are expressed as median and interquartile range [P(25)-P(75)]. Differences between groups were tested by non parametric tests. P < 0.05 was considered statistically significant. RESULTS: AF(adj )values were higher in ICU patients (0.33 [0.00 - 0.68]) than in controls (-0.07 [-0.29 - 0.24]; P < 0.001). No differences in skin AF(adj )were observed between acute or planned admissions, or presence of sepsis, nor was skin AF(adj )related to severity of disease as estimated by APACHE-II score, length of ICU, hospital stay or mortality. CONCLUSION: Acute AGE accumulation in ICU patients was shown in this study, although group size was small. This can possibly reflect oxidative stress in ICU patients. Further studies should reveal whether AGE-accumulation will be a useful parameter in ICU patients and whether skin AF has a predictive value for outcome, which was not shown in this small study.
format Text
id pubmed-2887805
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28878052010-06-19 Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study Greven, Wendela L Smit, Jitty M Rommes, Johannes H Spronk, Peter E BMC Clin Pathol Research article BACKGROUND: Oxidative stress plays an important role in the course and eventual outcome in a majority of patients admitted to the intensive care unit (ICU). Markers to estimate oxidative stress are not readily available in a clinical setting. AGEs accumulation has been merely described in chronic conditions, but can also occur acutely due to oxidative stress. Since AGEs have emerged to be stable end products, these can be a marker of oxidative stress. Skin autofluorescence (AF) is a validated marker of tissue content of AGEs. We hypothesized that AGEs accumulate acutely in ICU patients. METHODS: We performed an observational prospective study in a medical surgical ICU in a university affiliated teaching hospital. All consecutively admitted ICU patients in a 2 month period were included. Skin AF was measured using an AGE reader in 35 consecutive ICU patients > 18 yrs. As a comparison, historical data of a control group (n = 231) were used. These were also used to calculate age-adjusted AF-levels (AF(adj)). Values are expressed as median and interquartile range [P(25)-P(75)]. Differences between groups were tested by non parametric tests. P < 0.05 was considered statistically significant. RESULTS: AF(adj )values were higher in ICU patients (0.33 [0.00 - 0.68]) than in controls (-0.07 [-0.29 - 0.24]; P < 0.001). No differences in skin AF(adj )were observed between acute or planned admissions, or presence of sepsis, nor was skin AF(adj )related to severity of disease as estimated by APACHE-II score, length of ICU, hospital stay or mortality. CONCLUSION: Acute AGE accumulation in ICU patients was shown in this study, although group size was small. This can possibly reflect oxidative stress in ICU patients. Further studies should reveal whether AGE-accumulation will be a useful parameter in ICU patients and whether skin AF has a predictive value for outcome, which was not shown in this small study. BioMed Central 2010-05-25 /pmc/articles/PMC2887805/ /pubmed/20500823 http://dx.doi.org/10.1186/1472-6890-10-4 Text en Copyright ©2010 Greven et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Greven, Wendela L
Smit, Jitty M
Rommes, Johannes H
Spronk, Peter E
Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title_full Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title_fullStr Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title_full_unstemmed Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title_short Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
title_sort accumulation of advanced glycation end (ages) products in intensive care patients: an observational, prospective study
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887805/
https://www.ncbi.nlm.nih.gov/pubmed/20500823
http://dx.doi.org/10.1186/1472-6890-10-4
work_keys_str_mv AT grevenwendelal accumulationofadvancedglycationendagesproductsinintensivecarepatientsanobservationalprospectivestudy
AT smitjittym accumulationofadvancedglycationendagesproductsinintensivecarepatientsanobservationalprospectivestudy
AT rommesjohannesh accumulationofadvancedglycationendagesproductsinintensivecarepatientsanobservationalprospectivestudy
AT spronkpetere accumulationofadvancedglycationendagesproductsinintensivecarepatientsanobservationalprospectivestudy